Company Insider Tape

Xenon Pharmaceuticals Inc insider transactions

Executive and director filing history, acquisition and disposal balance, executive concentration, cadence, and stored market context.

Symbol XENE Latest filing 5 Jun 2026

Company Read

Net disposal

XENE has 34 stored insider filings. Acquisitions account for 64.7% of classified filings and disposals account for 35.3%. The largest stored filing is $75.6K from GANNON, STEVEN.

Latest filing 5 Jun 2026most recent stored row
Largest filing $75.6Kreported transaction value
Total filings 34stored transaction rows
Acquisition value $25.8K22 acquisitions
Disposal value $284.7K12 disposals
Net value $-258.9Kacquisitions minus disposals

Filing cadence

Last 12 active months
May 2026 2
Jun 2026 32

Acquisitions 64.7% · Disposals 35.3%

May 2026 $25.8K
Jun 2026 $284.7K

Executive concentration

By filing count
GANNON, STEVEN Director · 7 filings
SVORONOS, DAWN Director · 5 filings
PATOU, GARY Director · 5 filings
CANNON, GILLIAN Director · 5 filings
GOVER, JUSTIN D. Director · 4 filings
GAROFALO, ELIZABETH A. Director · 4 filings
MACHADO, PATRICK Director · 4 filings

Market Context

XENE weekly market snapshot

Week 24 Jul 2026
Latest close 65.42 USDstored weekly close
1-week move -4.2%latest weekly bar
13-week move +9.5%medium-term context
Relative Strength 28.4Sharemaestro indicator
Fair value gap +57.8%price vs fair value
Trend signal 1smoothed trend state

Transaction History

Latest insider filings for XENE

Showing 31-34 of 34
Date 1 Jun 2026
Insider PATOU, GARYDirector
Side Disposal
Shares 2645
Price 0.00
Value 0
Security Restricted Share Units
Date 1 Jun 2026
Insider SVORONOS, DAWNDirector
Side Disposal
Shares 2645
Price 0.00
Value 0
Security Restricted Share Units
Date 12 May 2026
Insider GANNON, STEVENDirector
Side Acquisition
Shares 3500
Price 7.38
Value 25830
Security Common Shares
Date 12 May 2026
Insider GANNON, STEVENDirector
Side Disposal
Shares 3500
Price 0.00
Value 0
Security Stock Option (Right to Buy)